-
1
-
-
68849108869
-
Inflammation and cancer: how friendly is the relationship for cancer patients?
-
Aggarwal B.B., Gehlot P. Inflammation and cancer: how friendly is the relationship for cancer patients?. Current Opinion in Pharmacology 2009, 9(4):351-369.
-
(2009)
Current Opinion in Pharmacology
, vol.9
, Issue.4
, pp. 351-369
-
-
Aggarwal, B.B.1
Gehlot, P.2
-
2
-
-
35348834104
-
PAI-1-a potential therapeutic target in cancer
-
Andreasen P.A. PAI-1-a potential therapeutic target in cancer. Current Drug Targets 2007, 8(9):1030-1041.
-
(2007)
Current Drug Targets
, vol.8
, Issue.9
, pp. 1030-1041
-
-
Andreasen, P.A.1
-
3
-
-
0030788411
-
The urokinase-type plasminogen activator system in cancer metastasis: a review
-
Andreasen P.A., Kjøller L., Christensen L., Duffy M.J. The urokinase-type plasminogen activator system in cancer metastasis: a review. International Journal of Cancer 1997, 72(1):1-22.
-
(1997)
International Journal of Cancer
, vol.72
, Issue.1
, pp. 1-22
-
-
Andreasen, P.A.1
Kjøller, L.2
Christensen, L.3
Duffy, M.J.4
-
4
-
-
63649152323
-
UPA and PAI-1 in rectal cancer-relationship to radiotherapy and clinical outcome
-
Angenete E., Langenskiöld M., Palmgren I., Falk P., Oresland T., Ivarsson M.L. uPA and PAI-1 in rectal cancer-relationship to radiotherapy and clinical outcome. Journal of Surgical Research 2009, 153(1):46-53.
-
(2009)
Journal of Surgical Research
, vol.153
, Issue.1
, pp. 46-53
-
-
Angenete, E.1
Langenskiöld, M.2
Palmgren, I.3
Falk, P.4
Oresland, T.5
Ivarsson, M.L.6
-
5
-
-
0035911151
-
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: implications for antiangiogenic strategies
-
Bajou K., Masson V., Gerard R.D., Schmitt P.M., Albert V., Praus M., Lund L.R., Frandsen T.L., Brunner N., Dano K., Fusenig N.E., Weidle U., Carmeliet G., Loskutoff D., Collen D., Carmeliet P., Foidart J.M., Noël A. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: implications for antiangiogenic strategies. The Journal of Cell Biology 2001, 152(4):777-784.
-
(2001)
The Journal of Cell Biology
, vol.152
, Issue.4
, pp. 777-784
-
-
Bajou, K.1
Masson, V.2
Gerard, R.D.3
Schmitt, P.M.4
Albert, V.5
Praus, M.6
Lund, L.R.7
Frandsen, T.L.8
Brunner, N.9
Dano, K.10
Fusenig, N.E.11
Weidle, U.12
Carmeliet, G.13
Loskutoff, D.14
Collen, D.15
Carmeliet, P.16
Foidart, J.M.17
Noël, A.18
-
6
-
-
79959879860
-
Dependence on endocytic receptor binding via a minimal binding motif underlies the differential prognostic profiles of SerpinE1 and SerpinB2 in cancer
-
Cochran B.J., Croucher D.R., Lobov S., Saunders D.N., Ranson M. Dependence on endocytic receptor binding via a minimal binding motif underlies the differential prognostic profiles of SerpinE1 and SerpinB2 in cancer. Journal of Biological Chemistry 2011, 286(27):24467-24475.
-
(2011)
Journal of Biological Chemistry
, vol.286
, Issue.27
, pp. 24467-24475
-
-
Cochran, B.J.1
Croucher, D.R.2
Lobov, S.3
Saunders, D.N.4
Ranson, M.5
-
7
-
-
77952322659
-
Mature human neutrophils constitutively express the transcription factor EGR-1
-
Cullen E.M., Brazil J.C., O'Connor C.M. Mature human neutrophils constitutively express the transcription factor EGR-1. Molecular Immunology 2010, 47(9):1701-1709.
-
(2010)
Molecular Immunology
, vol.47
, Issue.9
, pp. 1701-1709
-
-
Cullen, E.M.1
Brazil, J.C.2
O'Connor, C.M.3
-
8
-
-
80053495096
-
PAI-1: an integrator of cell signaling and migration
-
Czekay R.P., Wilkins-Port C.E., Higgins S.P., Freytag J., Overstreet J.M., Klein R.M., Higgins C.E., Samarakoon R., Higgins P.J. PAI-1: an integrator of cell signaling and migration. International Journal of Cell Biology 2011, 2011:562481.
-
(2011)
International Journal of Cell Biology
, vol.2011
, pp. 562481
-
-
Czekay, R.P.1
Wilkins-Port, C.E.2
Higgins, S.P.3
Freytag, J.4
Overstreet, J.M.5
Klein, R.M.6
Higgins, C.E.7
Samarakoon, R.8
Higgins, P.J.9
-
9
-
-
16844377832
-
Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease
-
Dellas C., Loskutoff D.J. Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thrombosis and Haemostasis 2005, 93(4):631-640.
-
(2005)
Thrombosis and Haemostasis
, vol.93
, Issue.4
, pp. 631-640
-
-
Dellas, C.1
Loskutoff, D.J.2
-
10
-
-
57349117608
-
Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver
-
Dimova E.Y., Kietzmann T. Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver. Thrombosis and Haemostasis 2008, 100(6):992-1006.
-
(2008)
Thrombosis and Haemostasis
, vol.100
, Issue.6
, pp. 992-1006
-
-
Dimova, E.Y.1
Kietzmann, T.2
-
11
-
-
12144289397
-
Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis
-
Durand M.K., Bødker J.S., Christensen A., Dupont D.M., Hansen M., Jensen J.K., Kjelgaard S., Mathiasen L., Pedersen K.E., Skeldal S., Wind T., Andreasen P.A. Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis. Thrombosis and Haemostasis 2004, 91(3):438-449.
-
(2004)
Thrombosis and Haemostasis
, vol.91
, Issue.3
, pp. 438-449
-
-
Durand, M.K.1
Bødker, J.S.2
Christensen, A.3
Dupont, D.M.4
Hansen, M.5
Jensen, J.K.6
Kjelgaard, S.7
Mathiasen, L.8
Pedersen, K.E.9
Skeldal, S.10
Wind, T.11
Andreasen, P.A.12
-
12
-
-
74749102185
-
Quantitative DNA methylation analysis of laser capture microdissected formalin-fixed and paraffin-embedded tissues
-
Gagnon J.F., Sanschagrin F., Jacob S., Tremblay A.A., Provencher L., Robert J., Morin C., Diorio C. Quantitative DNA methylation analysis of laser capture microdissected formalin-fixed and paraffin-embedded tissues. Experimental and Molecular Pathology 2010, 88(1):184-189.
-
(2010)
Experimental and Molecular Pathology
, vol.88
, Issue.1
, pp. 184-189
-
-
Gagnon, J.F.1
Sanschagrin, F.2
Jacob, S.3
Tremblay, A.A.4
Provencher, L.5
Robert, J.6
Morin, C.7
Diorio, C.8
-
13
-
-
24944439969
-
CpG methylation of the PAI-1 gene 5'-flanking region is inversely correlated with PAI-1 mRNA levels in human cell lines
-
Gao S., Skeldal S., Krogdahl A., Sørensen J.A., Andreasen P.A. CpG methylation of the PAI-1 gene 5'-flanking region is inversely correlated with PAI-1 mRNA levels in human cell lines. Thrombosis and Haemostasis 2005, 94(3):651-660.
-
(2005)
Thrombosis and Haemostasis
, vol.94
, Issue.3
, pp. 651-660
-
-
Gao, S.1
Skeldal, S.2
Krogdahl, A.3
Sørensen, J.A.4
Andreasen, P.A.5
-
14
-
-
77952047372
-
Epigenetic alterations of the SERPINE1 gene in oral squamous cell carcinomas and normal oral mucosa
-
Gao S., Nielsen B.S., Krogdahl A., Sørensen J.A., Tagesen J., Dabelsteen S., Dabelsteen E., Andreasen P.A. Epigenetic alterations of the SERPINE1 gene in oral squamous cell carcinomas and normal oral mucosa. Genes, Chromosomes & Cancer 2010, 49(6):526-538.
-
(2010)
Genes, Chromosomes & Cancer
, vol.49
, Issue.6
, pp. 526-538
-
-
Gao, S.1
Nielsen, B.S.2
Krogdahl, A.3
Sørensen, J.A.4
Tagesen, J.5
Dabelsteen, S.6
Dabelsteen, E.7
Andreasen, P.A.8
-
15
-
-
0032189936
-
Modulation of the proteolytic balance plasminogen activator/plasminogen activator inhibitor by enhanced N-myc oncogene expression or application of genistein
-
García de Veas R., Schweigerer L., Medina M.A. Modulation of the proteolytic balance plasminogen activator/plasminogen activator inhibitor by enhanced N-myc oncogene expression or application of genistein. European Journal of Cancer 1998, 34(11):1736-1740.
-
(1998)
European Journal of Cancer
, vol.34
, Issue.11
, pp. 1736-1740
-
-
García de Veas, R.1
Schweigerer, L.2
Medina, M.A.3
-
16
-
-
77951667019
-
Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment
-
Gramling M.W., Church F.C. Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment. Thrombosis Research 2010, 125(5):377-381.
-
(2010)
Thrombosis Research
, vol.125
, Issue.5
, pp. 377-381
-
-
Gramling, M.W.1
Church, F.C.2
-
17
-
-
79952996039
-
Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
-
Grivennikov S.I., Karin M. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Annals of the Rheumatic Diseases 2011, 70(Suppl. 1):i104-i108.
-
(2011)
Annals of the Rheumatic Diseases
, vol.70
, Issue.SUPPL. 1
-
-
Grivennikov, S.I.1
Karin, M.2
-
18
-
-
77950346282
-
Immunity, inflammation, and cancer
-
Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010, 140(6):883-899.
-
(2010)
Cell
, vol.140
, Issue.6
, pp. 883-899
-
-
Grivennikov, S.I.1
Greten, F.R.2
Karin, M.3
-
19
-
-
62649132399
-
Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients
-
Gupta A., Lotan Y., Ashfaq R., Roehrborn C.G., Raj G.V., Aragaki C.C., Montorsi F., Shariat S.F. Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. European Urology 2009, 55(5):1124-1133.
-
(2009)
European Urology
, vol.55
, Issue.5
, pp. 1124-1133
-
-
Gupta, A.1
Lotan, Y.2
Ashfaq, R.3
Roehrborn, C.G.4
Raj, G.V.5
Aragaki, C.C.6
Montorsi, F.7
Shariat, S.F.8
-
20
-
-
0026469377
-
Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines
-
Hollas W., Hoosein N., Chung L.W., Mazar A., Henkin J., Kariko K., Barnathan E.S., Boyd D. Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines. Thrombosis and Haemostasis 1992, 68(6):662-666.
-
(1992)
Thrombosis and Haemostasis
, vol.68
, Issue.6
, pp. 662-666
-
-
Hollas, W.1
Hoosein, N.2
Chung, L.W.3
Mazar, A.4
Henkin, J.5
Kariko, K.6
Barnathan, E.S.7
Boyd, D.8
-
21
-
-
84867644604
-
Role of plasminogen activator inhibitor-1 in urokinase's paradoxical in vivo tumor suppressing or promoting effects
-
Jing Y., Kovacs K., Kurisetty V., Jiang Z., Tsinoremas N., Merchan J.R. Role of plasminogen activator inhibitor-1 in urokinase's paradoxical in vivo tumor suppressing or promoting effects. Molecular Cancer Research 2012, 10(10):1271-1281.
-
(2012)
Molecular Cancer Research
, vol.10
, Issue.10
, pp. 1271-1281
-
-
Jing, Y.1
Kovacs, K.2
Kurisetty, V.3
Jiang, Z.4
Tsinoremas, N.5
Merchan, J.R.6
-
22
-
-
0025775629
-
Heterogeneity in plasminogen activator (PA) levels in human prostate cancer cell lines: increased PA activity correlates with biologically aggressive behavior
-
Keer H.N., Gaylis F.D., Kozlowski J.M., Kwaan H.C., Bauer K.D., Sinha A.A., Wilson M.J. Heterogeneity in plasminogen activator (PA) levels in human prostate cancer cell lines: increased PA activity correlates with biologically aggressive behavior. Prostate 1991, 18(3):201-214.
-
(1991)
Prostate
, vol.18
, Issue.3
, pp. 201-214
-
-
Keer, H.N.1
Gaylis, F.D.2
Kozlowski, J.M.3
Kwaan, H.C.4
Bauer, K.D.5
Sinha, A.A.6
Wilson, M.J.7
-
23
-
-
0141791288
-
Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells
-
Kraemer K., Fuessel S., Schmidt U., Kotzsch M., Schwenzer B., Wirth M.P., Meye A. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clinical Cancer Research 2003, 9(10 Pt 1):3794-3800.
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.10 PART 1
, pp. 3794-3800
-
-
Kraemer, K.1
Fuessel, S.2
Schmidt, U.3
Kotzsch, M.4
Schwenzer, B.5
Wirth, M.P.6
Meye, A.7
-
24
-
-
61649122594
-
Expression of urokinase-type plasminogen activator system in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy
-
Kumano M., Miyake H., Muramaki M., Furukawa J., Takenaka A., Fujisawa M. Expression of urokinase-type plasminogen activator system in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. Urologic Oncology 2009, 27(2):180-186.
-
(2009)
Urologic Oncology
, vol.27
, Issue.2
, pp. 180-186
-
-
Kumano, M.1
Miyake, H.2
Muramaki, M.3
Furukawa, J.4
Takenaka, A.5
Fujisawa, M.6
-
25
-
-
0036856355
-
MethPrimer: designing primers for methylation PCRs
-
Li L.C., Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002, 18(11):1427-1431.
-
(2002)
Bioinformatics
, vol.18
, Issue.11
, pp. 1427-1431
-
-
Li, L.C.1
Dahiya, R.2
-
26
-
-
84872018791
-
Genetic instability and CpG methylation in the 5'-flanking region of the PAI-1 gene in Chinese patients with gastric cancer
-
Liu J., Li X., Yu N., Yang Y.Q., Li X., Ye Z.Y., Li J.C. Genetic instability and CpG methylation in the 5'-flanking region of the PAI-1 gene in Chinese patients with gastric cancer. Genetics and Molecular Research 2012, 11(3):2899-2908.
-
(2012)
Genetics and Molecular Research
, vol.11
, Issue.3
, pp. 2899-2908
-
-
Liu, J.1
Li, X.2
Yu, N.3
Yang, Y.Q.4
Li, X.5
Ye, Z.Y.6
Li, J.C.7
-
27
-
-
0028802450
-
Diversity and modulation of plasminogen activator activity in human prostate carcinoma cell lines
-
Lyon P.B., See W.A., Xu Y., Cohen M.B. Diversity and modulation of plasminogen activator activity in human prostate carcinoma cell lines. Prostate 1995, 27(4):179-186.
-
(1995)
Prostate
, vol.27
, Issue.4
, pp. 179-186
-
-
Lyon, P.B.1
See, W.A.2
Xu, Y.3
Cohen, M.B.4
-
28
-
-
0035823504
-
Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis
-
McMahon G.A., Petitclerc E., Stefansson S., Smith E., Wong M.K., Westrick R.J., Ginsburg D., Brooks P.C., Lawrence D.A. Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. Journal of Biological Chemistry 2001, 276(36):33964-33968.
-
(2001)
Journal of Biological Chemistry
, vol.276
, Issue.36
, pp. 33964-33968
-
-
McMahon, G.A.1
Petitclerc, E.2
Stefansson, S.3
Smith, E.4
Wong, M.K.5
Westrick, R.J.6
Ginsburg, D.7
Brooks, P.C.8
Lawrence, D.A.9
-
29
-
-
40149088485
-
Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms
-
Menschikowski M., Hagelgans A., Gussakovsky E., Kostka H., Paley E.L., Siegert G. Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms. Neoplasia 2008, 10(3):279-286.
-
(2008)
Neoplasia
, vol.10
, Issue.3
, pp. 279-286
-
-
Menschikowski, M.1
Hagelgans, A.2
Gussakovsky, E.3
Kostka, H.4
Paley, E.L.5
Siegert, G.6
-
30
-
-
67651036210
-
Regulation of endothelial protein C receptor shedding by cytokines is mediated through differential activation of MAP kinase signaling pathways
-
Menschikowski M., Hagelgans A., Eisenhofer G., Siegert G. Regulation of endothelial protein C receptor shedding by cytokines is mediated through differential activation of MAP kinase signaling pathways. Experimental Cell Research 2009, 315(15):2673-2682.
-
(2009)
Experimental Cell Research
, vol.315
, Issue.15
, pp. 2673-2682
-
-
Menschikowski, M.1
Hagelgans, A.2
Eisenhofer, G.3
Siegert, G.4
-
31
-
-
80053635010
-
Modulators of induction of plasminogen activator inhibitor type-1 in HepG2 cells by transforming growth factor-β
-
Nakayama N., Nakamura T., Okada H., Iwaki S., Sobel B.E., Fujii S. Modulators of induction of plasminogen activator inhibitor type-1 in HepG2 cells by transforming growth factor-β. Coronary Artery Disease 2011, 22(7):468-478.
-
(2011)
Coronary Artery Disease
, vol.22
, Issue.7
, pp. 468-478
-
-
Nakayama, N.1
Nakamura, T.2
Okada, H.3
Iwaki, S.4
Sobel, B.E.5
Fujii, S.6
-
32
-
-
0036765688
-
Significance of plasminogen-activation system in the formation of macroscopic types and invasion in esophageal carcinoma
-
Nomiya T., Nemoto K., Miyachi H., Fujimoto K., Takahashi C., Takeda K., Matushita H., Ogawa Y., Takai Y., Yamada S. Significance of plasminogen-activation system in the formation of macroscopic types and invasion in esophageal carcinoma. Anticancer Research 2002, 22(5):2913-2916.
-
(2002)
Anticancer Research
, vol.22
, Issue.5
, pp. 2913-2916
-
-
Nomiya, T.1
Nemoto, K.2
Miyachi, H.3
Fujimoto, K.4
Takahashi, C.5
Takeda, K.6
Matushita, H.7
Ogawa, Y.8
Takai, Y.9
Yamada, S.10
-
33
-
-
0037709969
-
Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo
-
Pakneshan P., Xing R.H., Rabbani S.A. Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo. The FASEB Journal 2003, 17(9):1081-1088.
-
(2003)
The FASEB Journal
, vol.17
, Issue.9
, pp. 1081-1088
-
-
Pakneshan, P.1
Xing, R.H.2
Rabbani, S.A.3
-
34
-
-
33749069496
-
Quantitative multi-gene expression profiling of primary prostate cancer
-
Schmidt U., Fuessel S., Koch R., Baretton G.B., Lohse A., Tomasetti S., Unversucht S., Froehner M., Wirth M.P., Meye A. Quantitative multi-gene expression profiling of primary prostate cancer. Prostate 2006, 66(14):1521-1534.
-
(2006)
Prostate
, vol.66
, Issue.14
, pp. 1521-1534
-
-
Schmidt, U.1
Fuessel, S.2
Koch, R.3
Baretton, G.B.4
Lohse, A.5
Tomasetti, S.6
Unversucht, S.7
Froehner, M.8
Wirth, M.P.9
Meye, A.10
-
35
-
-
0035069305
-
Interleukin-6 and prostate cancer progression
-
Smith P.C., Hobisch A., Lin D.L., Culig Z., Keller E.T. Interleukin-6 and prostate cancer progression. Cytokine & Growth Factor Reviews 2001, 12(1):33-40.
-
(2001)
Cytokine & Growth Factor Reviews
, vol.12
, Issue.1
, pp. 33-40
-
-
Smith, P.C.1
Hobisch, A.2
Lin, D.L.3
Culig, Z.4
Keller, E.T.5
-
36
-
-
0036928732
-
Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells
-
Tran C.P., Lin C., Yamashiro J., Reiter R.E. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Molecular Cancer Research 2002, 1(2):113-121.
-
(2002)
Molecular Cancer Research
, vol.1
, Issue.2
, pp. 113-121
-
-
Tran, C.P.1
Lin, C.2
Yamashiro, J.3
Reiter, R.E.4
-
37
-
-
84866235383
-
The biochemistry, physiology and pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo
-
Van De Craen B., Declerck P.J., Gils A. The biochemistry, physiology and pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo. Thrombosis Research 2012, 130(4):576-585.
-
(2012)
Thrombosis Research
, vol.130
, Issue.4
, pp. 576-585
-
-
Van De Craen, B.1
Declerck, P.J.2
Gils, A.3
|